Pharmacotherapeutic options for the prevention of kidney transplant rejection: the evidence to date
Journal
Expert Opinion on Pharmacotherapy
Date Issued
2022-08
Author(s)
DOI
10.1080/14656566.2022.2102418
Abstract
Although early rejection episodes are successfully controlled, the problem of unrecognized production of de novo anti-HLA antibodies and associated chronic rejection still persists.